Form 8-K Precision Therapeutics For: Nov 30 - StreetInsider.com

12/07/18

WASHINGTON, D.C. 20549. FORM 8-K. CURRENT REPORT PURSUANT. TO SECTION 13 OR 15(d) OF THE. SECURITIES EXCHANGE ACT OF 1934.

[more]